Physician profile
Jeffrey Blackman
NPI 1538117908
$722.55
in general payments reported to CMS, 2019-2025
15 companies · $404 in 2025
The $404 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.12 · 2020: $41.00 · 2021: $42.17 · 2022: $18.63 · 2024: $130 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $406 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $405.55 |
| Education | $129.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $140.60 | 2024-2025 | |
| Novo Nordisk INC | $129.08 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $98.23 | 2019-2025 | Gardasil 9, M-M-R II, Vaxelis |
| Sanofi-Aventis U.S. LLC | $72.50 | 2025 | |
| Ironshore Pharmaceuticals INC. | $41.10 | 2019-2024 | |
| Pfizer INC. | $39.92 | 2019-2020 | |
| Alk-Abello, INC | $34.55 | 2025 | Neffy |
| Kaleo, INC. | $31.39 | 2019-2024 | Auvi-Q |
| Sanofi Pasteur INC. | $28.08 | 2021 | |
| Hologic Sales and Service, LLC | $24.91 | 2024 | Aptima |
| Chiesi USA, INC. | $18.78 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.63 | 2022 | |
| Glaxosmithkline, LLC. | $16.16 | 2024 | Bexsero |
| Collegium Pharmaceutical, INC. | $15.16 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $13.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Blackman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.